Top Stocks To Buy Today As Markets Get Back On Track With Moderna

Markets continue to march forward after witnessing a late decline yesterday. Prices of Moderna and Tesla have been driving the gains, as investors feel that the worst of the pandemic is over with vaccine hopes increasing and are bullish on Tesla after a stock split makes their shares more attainable for smaller investors. The virus relief package looks to be stuck in Congress at the moment, despite executive orders from the President over the weekend. In the bond markets, the yield on Treasuries rose along with a massive pullback in the price of gold. Our deep learning algorithms have parsed through the data and used Artificial Intelligence (“AI”) to help you spot the Top Buys for today.

Sign up for the free Forbes AI Investor newsletter here to join an exclusive AI investing community and get premium investing ideas before markets open.

Ameren Corp (AEE)

First, on the list today is Ameren Corp AEE , a company that operates as a public utility holding company in the United States. It operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. Our AI technology has identified factor scores of rated B in Technical, C in Growth, A in Momentum Volatility, and C in Quality Value for the stock that is up 6.72% for the year. As for the financials, revenue was $5646.0M in the last fiscal year compared to $5909.0M three years ago. Operating income grew by 2.65% in the last fiscal year to $1357.0M, lower compared to $1454.0M three years ago. EPS registered a growth rate of 2.07% in the last fiscal year and increased by 59.78% from $2.14 three years ago to $3.35 in the last fiscal year.  There was a steady rise in ROE to 10.44% in the last year compared to 7.26% three years ago. Forward 12M revenue is expected to grow at a rate of 2.27% over the next 12 months. The stock trades with a Forward 12M P/E of 22.45.

Recommended For You

MORE FROM FORBESAmeren (AEE)

DLH Holdings Corp (DLHC)

Next on the buy list is DLH Holdings Corp. DLH Holdings Corp provides healthcare and social services in the United States. It offers defense and veterans’ health solutions, including case management, physical and behavioral health examinations, and medical administration and logistics services. Our AI has assigned factor scores B in Growth, C in Momentum Volatility, and A in Quality Value for the stock that is up 93.11% for the year. Revenue grew by 32.6% to $160.39M in the last fiscal year and by 83.88% from $115.66M three years ago. Operating Income grew by 24.63% in the last fiscal year to $11.36M, growing by 113.53% from $6.63M three years ago. EPS continues to impress with a growth rate of 36.61% in the last fiscal year and 107.44% over the last three fiscal years.  EPS was $0.41 in the last fiscal year and $0.27 three years ago. ROE grew to 12.53% in the last year from 9.72% three years ago. The stock is trading with a reasonable Forward 12M P/E of 13.58.

MORE FROM FORBESDlh Holdings (DLHC)

Ingredion Inc (INGR)

Our AI technology has assigned Ingredion Inc INGR with factor scores of B in Technical, C in Growth, C in Momentum Volatility, and B in Quality Value. Ingredion Inc produces and sells starches and sweeteners for various industries. It operates through four regions: North America; South America; Asia Pacific; and Europe, Middle East, and Africa. The stock is down 11.24% for the year. As for the financials, revenue dropped slightly to $6209.0M in the last fiscal year compared to $6244.0M three years ago. Operating Income, on the other hand, increased to $698.0M in the last fiscal year from $880.0M three years ago. EPS also fell to $6.13 in the last fiscal year compared to $7.06 three years ago. ROE continues to be high at 16.47% in the last fiscal year, though lower than the level of 19.3% three years ago. Revenue is set to grow by 3.91% in the next 12 months. It is another stock in our list that has an attractive valuation and is trading at a Forward 12M P/E of 13.62.

MORE FROM FORBESIngredion (INGR)

Liberty Media Siriusxm Group (LSXMK)

Next on our list of Top Buy list is Liberty Media Siriusxm Group, with factor scores of C in Technical, B in Growth, C in Momentum Volatility, and A in Quality Value. Liberty Media Siriusxm Group transmits music, sports, entertainment, comedy, talk, news, traffic, and weather channels in the United States and Canada. The company also provides infotainment services; and streaming services through applications for mobile and home devices, and other consumer electronic equipment, as well as online.  The stock is down 24.56% for the year. Digging into the financials, revenue grew by 2.67% over the fiscal year to $7794.0M, compared to a growth rate of 47.5%from $5425.0M three years ago. Operating Income grew by 1.11% over the last fiscal year to $1628.0M in the last fiscal year, growing by 6.4% from $1547.0M three years ago. EPS increased by 25.23% in the last year to $1.53, though it was lower compared to the figure three years back when it was $3.31. There was some pressure on ROE as it reduced to 4.59% compared to 10.21% three years back. Revenue is expected to grow by 0.92% over the next 12 months and the stock is trading with a Forward 12M P/E of 25.13.

MORE FROM FORBESLiberty Media Siriusxm Group (LSXMK)

Xperi Holding Corp (XPER)

Finally, we have Xperi Holding Corp as the last entry in our list of Top Buys. Xperi Holding Corp. develops, and delivers various technologies worldwide. Its technologies that enable extraordinary experiences are integrated into consumer devices, media platforms, and semiconductors. The stock is down 18.04%. Our AI systems have identified factor scores of rated C in Technical, A in Growth, B in Momentum Volatility, and A in Quality Value. As for the financials, revenue grew by 44.14% in the last fiscal year to $280.07M, which is a growth of 8.01% over the last three fiscal years from $373.73M. Operating Income grew by 397.46% over the last three fiscal years to $(58.94)M in the last fiscal year from $5.0M three years ago. EPS was $(1.27) in the last fiscal year compared to $(1.15) three years ago. ROE was negative at (11.01%) in the last year, slightly better when compared to (11.99%) three years ago. Revenue is expected to grow by 27.59% in the next 12 months. The stock is available at a Forward 12M P/E of 25.0.

MORE FROM FORBESXperi (XPER)

Liked what you read? Sign up for our free Forbes AI Investor Newsletter here to get AI driven investing ideas weekly. For a limited time, subscribers can join an exclusive slack group to get these ideas before markets open.

Comments are closed.